Clinical Trials

Clinical trials and studies about imaging technology can be found on this channel.

72-year-old with intermediate (50-70%) stenosis in distal right coronary artery, who underwent coronary CTA due to atypical chest pain.

Rapid Onsite FFR-CT Algorithm Helps Facilitates Clinical Adoption

May 5, 2023 — According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR), a high ...

May 05, 2023

Using a harmless glucose solution, the procedure generates reliable results

News | Magnetic Resonance Imaging (MRI)

Pioneering MRI Imaging Method Captures Brain Glucose Metabolism Without the Need for Administration of Radioactive Substances

May 2, 2023 — Metabolic disorders are involved in many common health conditions such as Alzheimer's, depression ...

May 02, 2023

Results show Black women had significantly higher rates of radiation therapy recommendation compared to White women with similar biosignature scores

News | Radiation Therapy

PreludeDx Presents Comparative Data Analyzing Racial/Ethnic Radiation Therapy Treatment Recommendation Changes using DCISionRT

May 1, 2023 — Prelude Corporation (PreludeDx), a leader in molecular diagnostics and precision medicine for early-stage ...

May 01, 2023

Researchers at the University of Illinois Urbana Champaign have developed a dual-modality imaging technique that not only delivers comprehensive diagnostic information but also provides a cost-effective solution for healthcare providers

News | Radiology Imaging

Researchers Develop New Lower Cost, Dual-modality Imaging Technique to Facilitate Earlier Disease Detection

April 24, 2023 — Diagnostic imaging is indispensable in healthcare, as it allows clinicians to detect and diagnose a ...

April 24, 2023

The CEO of the American College of Radiology, William T. Thorwarth, MD, FACR, recently presented testimony to the U.S. House Labor, Health and Human Services, Education, and Related Agencies Appropriations Subcommittee, in support of increased funding for the National Institutes of Health (NIH) in FY 2024.

News | ACR

American College of Radiology (ACR) Leader Delivers Testimony in Support of NIH Funding, Highlights Examples of Radiology and Imaging Advancements

April 4, 2023 — In support of an increased funding recommendation for the National Institutes of Health (NIH) in federal ...

April 04, 2023

New data suggests diagnostic errors in neuroradiology were associated with longer interpretation times, higher shift volumes, and weekend interpretation

News | Clinical Trials

Diagnostic Errors in Neuroradiology: More Time, Higher Volume, Weekend Work

March 30, 2023 —According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR) ...

March 30, 2023

Researchers found that a minimally invasive procedure combined with epidural steroid injection treatment led to superior pain reduction and disability improvement over one year in patients with sciatica.

News | Interventional Radiology

Pulsed Radiofrequency with Steroid Injection Brings Sciatica Relief

March 28, 2023 — Researchers found that a minimally invasive procedure combined with epidural steroid injection ...

March 28, 2023

Novel optical imaging agent highlights cancerous tissue during initial lumpectomy to enable a more complete resection as part of the investigational Lumicell Direct Visualization System

News | Breast Imaging

Lumicell Submits New Drug Application for Lumisight Optical Imaging Agent to U.S. FDA for Intraoperative Breast Cancer Detection and Removal

March 23, 2023 — Lumicell, Inc., a privately held company focused on innovative fluorescence-guided imaging technologies ...

March 24, 2023

News | PET Imaging

Nuclidium and University Hospital Basel Receive NETRF Investigator Award to Initiate Phase 1 Trial with Novel Copper-based Radiotheranostic Program TraceNET in Neuroendocrine Tumors

March 23, 2023 — Nuclidium announced that the Neuroendocrine Tumors Research Foundation (NETRF) has selected the company ...

March 24, 2023

Positron Corporation, a molecular imaging device company that offers PET imaging systems and clinical services, is pleased to announce that it has executed a Clinical Study/Research Agreement with Ochsner Clinic Foundation

News | PET-CT

Positron Corporation Enters into Agreement with Ochsner Clinic Foundation for Clinical Study of its New “Affinity PET-CT 4D” Device

March 21, 2023 — Positron Corporation, a molecular imaging device company that offers PET imaging systems and clinical ...

March 21, 2023

RYZ101 positioned to be the first approved Actinium-225 radiopharmaceutical therapy for the industry

News | Radiopharmaceuticals and Tracers

RayzeBio Completes Phase 1b Enrollment in ACTION-1 Study, Evaluating RYZ101 (Actinium-225 DOTATATE) in Neuroendocrine Tumors

March 20, 2023 — RayzeBio, Inc., a targeted radiopharmaceutical company developing an innovative pipeline against ...

March 20, 2023

UNSW Sydney researchers develop algorithm to significantly enhance images of hydrogen fuel cells, with potential future application in medical scanning

News | X-Ray

Deep Learning Tool Boosts X-ray Imaging Resolution and Hydrogen Fuel Cell Performance

March 20, 2023 — Researchers from UNSW Sydney have developed an algorithm which produces high-resolution modeled images ...

March 20, 2023

Novel manganese-based macrocyclic Magnetic Resonance Imaging (MRI) agent could offer an alternative to gadolinium-based agents

News | Contrast Media

GE HealthCare Announces Completion of Phase I Subject Recruitment in Early Clinical Development Program for a First-of-its-Kind Macrocyclic Manganese-Based MRI Contrast Agent

March 2, 2023 — GE HealthCare announced at the European Congress of Radiology (ECR) in Vienna, Austria, the completion ...

March 02, 2023

Study compared models of personal risk to current USPSTF screening guidelines

News | Lung Imaging

Lung Cancer Screening More Cost Effective When Using Risk Model-Based Strategies

February 10, 2023 — Risk model-based lung cancer screening strategies, which select individuals based on personal risk ...

February 10, 2023

Researcher conducts a breast cancer vaccine related experiment in a lab at Cleveland Clinic.

News | Clinical Trials

Cleveland Clinic Announces Next Step in Preventive Breast Cancer Vaccine Study

February 8, 2023 — Cleveland Clinic researchers have launched the next step in their novel study of a vaccine aimed at ...

February 08, 2023

The V Foundation for Cancer Research has announced a new grant program aimed at increasing female representation and female-led innovation in cancer research.

News | Radiation Oncology

New Grant Program by the V Foundation Established to Boost Female-led Cancer Research

February 2, 2023 — The V Foundation, a top cancer research charity, has announced the establishment of a new grant ...

February 02, 2023

PRISMA flow diagram shows identification, screening, and inclusion of studies

News | Magnetic Resonance Imaging (MRI)

MRI Surveillance for Postsurgical Musculoskeletal Soft-Tissue Sarcomas

February 1, 2023 — According to an accepted manuscript published in ARRS’ American Journal of Roentgenology (AJR), MRI ...

February 01, 2023

Study finds that Black patients and patients living in certain regions experience greater delays.

News | Breast Imaging

Race and Geography Linked to Different Risks of Breast Cancer Treatment Delays

January 24, 2023 — For patients with cancer, lengthy delays in treatment can decrease their chances of survival. In an ...

January 24, 2023

Deciphex, a Dublin-based software company focused on developing digital pathology-based software and services for clinical and research pathology, has announced the rollout of its Automated Image Quality Control (QC) for digital research pathology.

News | Digital Pathology

Digital Pathology Software Firm Deciphex Builds Automated Image QC into Research Platform

January 19, 2023 — In an effort to speed up the research study process, Deciphex has announced the rollout of its ...

January 19, 2023

December 29, 2022 — Anthracyclines are a class of chemotherapies effective in treating many forms of cancer, including leukemias, lymphomas and breast cancer. Anthracyclines — such as doxorubicin, frequently used against breast cancer — kill cancer cells by damaging their DNA. However, these effective chemotherapies also cause toxic effects in the heart in about ten percent of patients that can eventually lead to heart failure, particularly in older patients with pre-existing cardiovascular disease. Current

News | Breast Imaging

Researchers ID Protein that may Protect the Heart During Certain Cancer Treatment Regimens

December 29, 2022 — Anthracyclines are a class of chemotherapies effective in treating many forms of cancer, including ...

December 29, 2022